Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

NYSE:CE - US1508701034 - Common Stock

47.32 USD
-1.31 (-2.69%)
Last: 8/25/2025, 8:09:16 PM
46.7522 USD
-0.57 (-1.2%)
After Hours: 8/25/2025, 8:09:16 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CE. CE was compared to 84 industry peers in the Chemicals industry. Both the profitability and financial health of CE have multiple concerns. CE is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CE had positive earnings in the past year.
CE had a positive operating cash flow in the past year.
CE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CE had a positive operating cash flow.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

With a Return On Assets value of -6.83%, CE is not doing good in the industry: 72.62% of the companies in the same industry are doing better.
CE's Return On Equity of -30.71% is on the low side compared to the rest of the industry. CE is outperformed by 76.19% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.49%, CE is in line with its industry, outperforming 46.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CE is below the industry average of 6.43%.
Industry RankSector Rank
ROA -6.83%
ROE -30.71%
ROIC 3.49%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Operating Margin of CE (9.38%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CE has declined.
CE's Gross Margin of 21.85% is on the low side compared to the rest of the industry. CE is outperformed by 60.71% of its industry peers.
CE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.38%
PM (TTM) N/A
GM 21.85%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

CE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CE has been increased compared to 1 year ago.
Compared to 5 years ago, CE has less shares outstanding
Compared to 1 year ago, CE has a worse debt to assets ratio.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

CE has an Altman-Z score of 1.53. This is a bad value and indicates that CE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.53, CE is doing worse than 66.67% of the companies in the same industry.
The Debt to FCF ratio of CE is 20.48, which is on the high side as it means it would take CE, 20.48 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.48, CE perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
A Debt/Equity ratio of 2.43 is on the high side and indicates that CE has dependencies on debt financing.
With a Debt to Equity ratio value of 2.43, CE is not doing good in the industry: 84.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 20.48
Altman-Z 1.53
ROIC/WACC0.46
WACC7.51%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CE has a Current Ratio of 2.05. This indicates that CE is financially healthy and has no problem in meeting its short term obligations.
CE has a Current ratio (2.05) which is in line with its industry peers.
CE has a Quick Ratio of 1.22. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.22, CE perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.22
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

CE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.87%.
The Earnings Per Share has been decreasing by -2.59% on average over the past years.
CE shows a decrease in Revenue. In the last year, the revenue decreased by -5.83%.
Measured over the past years, CE shows a quite strong growth in Revenue. The Revenue has been growing by 10.30% on average per year.
EPS 1Y (TTM)-35.87%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-39.5%
Revenue 1Y (TTM)-5.83%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-4.49%

3.2 Future

Based on estimates for the next years, CE will show a small growth in Earnings Per Share. The EPS will grow by 5.09% on average per year.
The Revenue is expected to grow by 0.51% on average over the next years.
EPS Next Y-46%
EPS Next 2Y-13.62%
EPS Next 3Y-1.59%
EPS Next 5Y5.09%
Revenue Next Year-5.16%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.48%
Revenue Next 5Y0.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.02, the valuation of CE can be described as very reasonable.
Based on the Price/Earnings ratio, CE is valued cheaper than 90.48% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. CE is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 7.59, the valuation of CE can be described as very cheap.
CE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CE is cheaper than 91.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. CE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.02
Fwd PE 7.59
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

61.90% of the companies in the same industry are more expensive than CE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CE is valued cheaply inside the industry as 89.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.2
EV/EBITDA 9.8
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.62%
EPS Next 3Y-1.59%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.27%, CE is not a good candidate for dividend investing.
CE's Dividend Yield is slightly below the industry average, which is at 3.54.
With a Dividend Yield of 0.27, CE pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.27%

5.2 History

The dividend of CE has a limited annual growth rate of 3.06%.
CE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CE decreased recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-9.81%
EPS Next 2Y-13.62%
EPS Next 3Y-1.59%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (8/25/2025, 8:09:16 PM)

After market: 46.7522 -0.57 (-1.2%)

47.32

-1.31 (-2.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners102.77%
Inst Owner Change5.36%
Ins Owners0.27%
Ins Owner Change3.12%
Market Cap5.18B
Analysts71.54
Price Target55.92 (18.17%)
Short Float %5.92%
Short Ratio3.13
Dividend
Industry RankSector Rank
Dividend Yield 0.27%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-9.81%
Div Incr Years0
Div Non Decr Years1
Ex-Date07-29 2025-07-29 (0.03)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.13%
Min EPS beat(2)-0.14%
Max EPS beat(2)44.41%
EPS beat(4)2
Avg EPS beat(4)11.14%
Min EPS beat(4)-16.92%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.27%
EPS beat(12)5
Avg EPS beat(12)1.38%
EPS beat(16)7
Avg EPS beat(16)2.17%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)2.89%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.21%
Revenue beat(12)1
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-2.02%
PT rev (1m)-14.19%
PT rev (3m)-10.06%
EPS NQ rev (1m)-24.27%
EPS NQ rev (3m)-33.51%
EPS NY rev (1m)-14.25%
EPS NY rev (3m)-13.58%
Revenue NQ rev (1m)-1.9%
Revenue NQ rev (3m)-4.12%
Revenue NY rev (1m)-0.84%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 8.02
Fwd PE 7.59
P/S 0.52
P/FCF 8.2
P/OCF 5.08
P/B 0.98
P/tB N/A
EV/EBITDA 9.8
EPS(TTM)5.9
EY12.47%
EPS(NY)6.23
Fwd EY13.17%
FCF(TTM)5.77
FCFY12.2%
OCF(TTM)9.32
OCFY19.69%
SpS90.77
BVpS48.18
TBVpS-36.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -30.71%
ROCE 4.45%
ROIC 3.49%
ROICexc 3.7%
ROICexgc 6.89%
OM 9.38%
PM (TTM) N/A
GM 21.85%
FCFM 6.36%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexcg growth 3Y-25.53%
ROICexcg growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 20.48
Debt/EBITDA 7.49
Cap/Depr 49.62%
Cap/Sales 3.9%
Interest Coverage 250
Cash Conversion 59.51%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.22
Altman-Z 1.53
F-Score4
WACC7.51%
ROIC/WACC0.46
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.87%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-39.5%
EPS Next Y-46%
EPS Next 2Y-13.62%
EPS Next 3Y-1.59%
EPS Next 5Y5.09%
Revenue 1Y (TTM)-5.83%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-4.49%
Revenue Next Year-5.16%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.48%
Revenue Next 5Y0.51%
EBIT growth 1Y-19.24%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year27.28%
EBIT Next 3Y14.68%
EBIT Next 5Y9.93%
FCF growth 1Y-41.64%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-39.07%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%